Site içinde arama yapın

bir ses eklendi Health

2026-06-25 10:50:08 -

Charles Bonnet Syndrome Market: Can Better Awareness and Pharmacological Innovation Finally Address This Misunderstood Condition?

The global Charles Bonnet Syndrome Market is growing from USD 0.87 billion in 2025 to USD 1.48 billion by 2035 at a CAGR of 5.48% — and much of that growth is being driven by something more fundamental than new drug approvals: the simple act of recognizing the condition exists. Charles Bonnet Syndrome (CBS) is a neurological condition in which people with significant vision loss...

0 Yorumlar 0 hisse senetleri 129 Views 0 önizleme